Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Gilead Sciences acquires CGI Pharmaceuticals for up to $120mm

Executive Summary

To broaden its research capabilities into the field of kinase biology and small-molecule chemistry, Gilead Sciences Inc. is acquiring privately held CGI Pharmaceuticals Inc., paying a potential $120mm in cash; most of it up front and the rest in earn-outs should CGI achieve certain clinical development milestones.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Contract
    • Acquisition of Private Biotech
    • Payment Includes Cash
    • Full Acquisition
    • Includes Earnout
    • Intra-Biotech Deal

Related Companies